Details of the Drug Reposition

General Information of This Drug (ID: DM6NIZD)

Drug Name
Gilotrif   DM6NIZD
Synonyms
Afatinib dimaleate; AFATINIB DIMALEATE; 850140-73-7; Afatinib (diMaleate); UNII-V1T5K7RZ0B; BIBW 2992MA2; Afatinib dimaleate [USAN]; V1T5K7RZ0B; CHEBI:76003; Afatinib (BIBW2992) Dimaleate; Afatinib maleate; Afatinib dimaleate (USAN); Giotrif; Gilotrif (TN); Giotrif (TN); Afatinib maleate (JAN); (2E)-N-(4-((3-Chloro-4-fluorophenyl)amino)-7-(((3S)-tetrahydrofuran-3-yl)oxy)quinazolin- 6-yl)-4-(dimethylamino)but-2-enamide bis(hydrogen (2Z)-but-2-enedioate); BIBW2992 MA2; CHEMBL2105712; USNRYVNRPYXCSP-JUGPPOIOSA-N; MolPort-028-744-902; AOB873
Structure
3D MOL 2D MOL

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
2 Phase 3 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Squamous cell carcinoma DISQVIFL 2B60-2D01 Phase 3 [1]
Breast cancer DIS7DPX1 2C60-2C65 Phase 3 [1]
------------------------------------------------------------------------------------
1 Phase 2 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Glioma DIS5RPEH 2A00.0 Phase 2 [1]
------------------------------------------------------------------------------------

References

1 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)